| Literature DB >> 30345282 |
Andreas Drolz1, Arnulf Ferlitsch2,3, Valentin Fuhrmann1,4.
Abstract
Alterations in hemostasis are a characteristic feature of advanced liver disease. Patients with coagulopathy of advanced liver disease are prone to bleedings and also thromboembolic events. Under stable conditions, cirrhosis patients show alterations in both pro- and anticoagulatory pathways, frequently resulting in a rebalanced hemostasis. This review summarizes current recommendations of management during bleeding and prior to invasive procedures in patients with cirrhosis.Entities:
Keywords: Acute liver failure; Anticoagulation; Bleeding; Cirrhosis; Portal hypertension
Year: 2018 PMID: 30345282 PMCID: PMC6189540 DOI: 10.1159/000491106
Source DB: PubMed Journal: Visc Med ISSN: 2297-4725